CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway
about
Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteinsRegulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4)A glimpse of the ERM proteinsMembrane trafficking of death receptors: implications on signallingRho kinase proteins--pleiotropic modulators of cell survival and apoptosisA novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ezrin/radixin/moesin-directed subcellular targetingHuman immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell deathExpression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosisRaf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signalingPalmitoylation is required for efficient Fas cell death signalingEndothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesionCytoplasmic death signal triggered by SRC-mediated phosphorylation of the adenovirus E4orf4 protein.The unique localization of ZFP185 at uropod of mouse T lymphocytes.Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.Ezrin is highly expressed in early thymocytes, but dispensable for T cell development in mice.Rho1 regulates apoptosis via activation of the JNK signaling pathway at the plasma membrane.Major histocompatibility complex class II inhibits fas antigen-mediated gastric mucosal cell apoptosis through actin-dependent inhibition of receptor aggregationFas activation induces renal tubular epithelial cell beta 8 integrin expression and function in the absence of apoptosis.Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.Imaging of T-cell interactions with antigen presenting cells in culture and in intact lymphoid tissue.Membrane-cytoskeleton interactions during the formation of the immunological synapse and subsequent T-cell activation.Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions.Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells.Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells.Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes.The actin cytoskeleton as a sensor and mediator of apoptosisInduction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.Cellular transcriptomics: gelsolin negatively regulates the expression of apoptosis-associated genes and inhibits apoptosis in hepatocarcinoma cells.Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells.Regulation of cell survival by Na+/H+ exchanger-1.Expression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testis.Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy.Re-defining ERM function in lymphocyte activation and migration.Principles and mechanisms of CD95 activation.Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.Diagnostic significance of serum concentrations of soluble Fas ligand (sFasL) in children with autoimmune thyroid disease.Combined gene expression and proteomic analysis of EGF induced apoptosis in A431 cells suggests multiple pathways trigger apoptosis.Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid raftsExpression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells.
P2860
Q24302055-C1D7D812-00CD-457E-A5BE-8F0E78A1CE3BQ24673747-C6142EBD-5F04-4837-9FE3-36E659C94BA4Q26765004-F6DB41D2-3CD1-45BC-AA4D-961155615B9EQ26852802-C31C052F-41C7-45E8-9815-CB6AADD64E78Q27023537-6910D5BB-B8EC-4CFB-B4CA-EE3DD7BFE29DQ28215157-26A312CF-D960-4865-BAE1-BB13CCF9D25EQ28244192-169CA6B6-2B9C-441E-92F5-0583D3B11DE7Q28363205-7DAB6ADD-1B6F-4C53-A62B-8EF051548A18Q28504557-E5A21151-8EED-492B-A525-DB1049CE50A7Q28591409-B26769A3-D068-487E-9443-1AC20A938F76Q28821976-5EC03337-36F3-4A38-9599-FCC53AE28BCCQ30453323-96352093-C0E5-43AB-8DB2-FABD0A004DF2Q33324542-C5EC2320-1928-49C7-9821-526970BF6F4EQ33672489-07B02D6F-D0DA-43FB-AEF6-28D894BB7AC6Q33678939-0D2DDC64-5160-4562-814C-D7274CE88764Q33799194-040893E1-E220-4D2B-97E4-EC82CE78523BQ34033204-B0E01D7F-73D3-406C-99DE-937FA1DDD728Q34151685-703B24A8-AEAE-4F9D-9A9F-2FA5E7F363C2Q34332353-A0F922A7-78F6-4937-9264-B5B456198607Q35005860-3A05D580-8B34-4D0C-B7A5-593C3EA123E3Q35005880-40B96573-8E90-405C-9D75-5EFDE3D5C044Q35114657-3A739437-09CB-4772-AA55-845B42EB56D6Q35641622-FC988D5F-686B-4C21-A82D-4EA656E0BB6FQ35750901-63990836-8BB2-4E6A-B93B-2608BAE793B8Q35775396-F2C1045A-DDEA-40F5-BA9E-C6A27D91A8FEQ36149204-77E74B95-1A8D-4C45-89D8-3B0C99236C1FQ36370300-D7EA5862-AD9E-4405-8A97-42DCD5D8EE39Q36464279-E13B883B-2B68-43DA-AC52-5F7166E87869Q36809463-1B29DA9D-F564-44F6-BDD8-0A0B6CFB65D4Q37121628-09430A52-DDFB-494A-BC56-AD0938599DA0Q37149345-D6729DF0-E9B6-4686-864C-08E309BEC33DQ37750797-FBF04082-BF7C-4F83-899B-6D0273CF84FDQ38151846-7DE764A3-7861-43FE-ADBE-62E5DCB74018Q38242897-10BE8676-4898-4E4A-A82B-2EBD18DAD965Q38363543-F3217B90-C377-429F-B40E-8A97CBC4950CQ38368921-0030E165-7315-4266-BEEF-63D9A42552A0Q38918746-650C81B2-3DEA-4CA1-9E2C-D3620AEB62FDQ39119280-1FC2680D-ABDF-4D02-97A6-DEC4BB93E93CQ39340173-57A4E679-BD4D-463C-8EA7-DDEE4F428CEFQ39359766-AFA35AC6-5F17-48CD-911E-7BDCBCA4832F
P2860
CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@ast
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@en
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@nl
type
label
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@ast
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@en
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@nl
prefLabel
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@ast
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@en
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
CD95 (APO-1/Fas) linkage to th ...... of the CD95 apoptotic pathway
@en
P2093
A M Giammarioli
F Lozupone
P2860
P304
P3181
P356
10.1093/EMBOJ/19.19.5123
P407
P577
2000-10-01T00:00:00Z